human-papillomavirus

Documents about human-papillomavirus

• Accuracy of Portable Colposcopy and HPV Genotypes Among HIV+ Women#875178ClinicalTrials.gov
• Promoting HPV Vaccination Among Young Adults in Texas#67658ClinicalTrials.gov
• Phase I Clinical Trial of a Candidate HPV Vaccine#343705ClinicalTrials.gov
• Immune Response to the Human Papillomavirus Vaccine in Young Women With Inflammatory Bowel Disease#844979ClinicalTrials.gov
• Monitoring the safety of the adjuvanted human papillomavirus vaccine HPV-16/18-AS04 in association with pregnancy and potential immune-related diseases in China: A retrospective observational cohort study#478548Europe PMC
• The Effect of Health Belief Model-Based Education and Motivational Interviewing on HPV (Human Papilloma Virus) Knowledge and Vaccine Awareness in Women#855158ClinicalTrials.gov
• txt2protect: Using Text Messaging to Increase HPV Vaccination Among Young Sexual Minority Men#143673ClinicalTrials.gov
• Testing RG1-VLP Vaccine to Prevent HPV-related Cancers#174975ClinicalTrials.gov
• Human Papillomavirus Vaccine Therapy in Treating Men With HIV-1 Infection#238166ClinicalTrials.gov
• Increasing Optimal Use of HPV Vaccination in Primary Care#640449ClinicalTrials.gov
• Table 1_Bacterial vaginosis is significantly associated with a higher risk of high-risk human papillomavirus persistence: a cohort study in Nairobi, Kenya.docx#329776Figshare
• Table 2_Bacterial vaginosis is significantly associated with a higher risk of high-risk human papillomavirus persistence: a cohort study in Nairobi, Kenya.docx#329777Figshare
• Human Papillomavirus (HPV) Vaccination Coverage Estimates Among Adolescent Females within the Delta Regional Authority Using National Immunization Survey Teen (NIS-Teen) 2008 - 2012.#492377ScholarWorks@GSU
• The Durability of Protection Study of a Recombinant HPV 16/18 Bivalent Vaccine in Female#810308ClinicalTrials.gov
• Efficacy Against Oral Persistent Infection, Immunogenicity and Safety of the 9-valent Human Papillomavirus Vaccine (9vHPV) in Men Aged 20-45 Years (V503-049)#899617ClinicalTrials.gov
• A Phase III Study of a 2-dose Regimen of a Multivalent Human Papillomavirus (HPV) Vaccine (V503), Administered to 9 to 14 Year-olds and Compared to Young Women, 16 to 26 Years Old (V503-010)#217098ClinicalTrials.gov
• Innovative Tool to Increase Completion of Human Papillomavirus (HPV) Vaccine Series#141104ClinicalTrials.gov
• Developing a Self-persuasion Intervention Promoting Adolescent HPV Vaccination#146272ClinicalTrials.gov
• Interleukin 4 and Interferon Gamma Predictors of Human Papillomavirus Immunotherapy in Warts#217040ClinicalTrials.gov
• A Vaccine Promotion Package (TweenVax) to Improve Adolescent HPV Vaccination, TweenVax Trial#623548ClinicalTrials.gov
• Safety and Tolerability of GX-I7 in HPV-infected Female Volunteers#873734ClinicalTrials.gov
• A Phase 1 Study of PV-001 9-valent Human Papillomavirus(HPV) Vaccine#903346ClinicalTrials.gov
• Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus Vaccine (Cervarix™) When Co-administered With GSK Biologicals' Hepatitis A Vaccine (Havrix®) in Healthy Female Adolescents Aged 9-14 Years#307317ClinicalTrials.gov
• One-year impact on HPV vaccination coverage of a school- and primary care-based intervention: the PrevHPV cluster randomised trial#311946HAL (France)
• 42 U.S.C. § 247b-17 — Human papillomavirus (Johanna’s Law)#595380US Code (LII)
• Occupational Human Papillomavirus Exposure Risks for Laryngeal Surgeons and Phoniatricians: A Joint European Laryngological Society (ELS) and Union of European Phoniatricians (UEP) Delphi Clinical Consensus Statement#1001634ODU Digital Commons
• Human papillomavirus awareness and vaccination willingness among male community residents in Beijing based on the Health Belief Model.#9898PubMed
• Immunogenicity of Gardasil-9 HPV Vaccine in People Living With HIV#398196ClinicalTrials.gov
• Baseline characteristics of the HOMINY (human papillomavirus, human immunodeficiency virus, and oral microbiota interplay in Nigerian youth) prospective longitudinal cohort.#449912NCBI PubMed Central
• The Immunogenicity and Safety of the Vaccination of Human Papillomavirus Vaccine and Measles-Mumps-Rubella Vaccine#862844ClinicalTrials.gov
• Dose-Ranging Study of Recombinant Human Papillomavirus Virus 16/18 Bivalent Vaccine#136410ClinicalTrials.gov
• Human Papillomavirus (HPV) Vaccination vs. Placebo for the Treatment of Refractory Cutaneous Warts#256946ClinicalTrials.gov
• THE EFFECTS OF HPV VACCİNATİON AND MESSAGE FRAMİNG#332807ClinicalTrials.gov
• A Comparison of Cotton and Flocked Swabs for Vaginal Self Collection#829358ClinicalTrials.gov
• Treatment of Plane Warts With Topical and Oral Retinoids#837524ClinicalTrials.gov
• ICI-VPH: Impact of HPV Immunisation Schedules Against HPV#894074ClinicalTrials.gov
• Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' Human Papillomavirus (HPV) Vaccine (GSK-580299) and Merck's Gardasil Vaccine When Administered According to Alternative 2-dose Schedules in 9-14 Year Old Females#67673ClinicalTrials.gov
• Informational Video Gaming in the Waiting Room#369771BYU ScholarsArchive
• Maximizing HPV Vaccination: Real-time Reminders, Guidance, and Recommendations - Part 4: Feasibility Trial#158044ClinicalTrials.gov
• Trial of Two Versus Three Doses of Human Papillomavirus (HPV) Vaccine in India#174959ClinicalTrials.gov
• High-risk human papillomavirus genotypes in cervical squamous cell carcinomas diagnosed in Rwanda.#236364NCBI PubMed Central
• Vaginal Microecological Imbalance, Human Papillomavirus Infection, and Cervical Carcinogenesis: Mechanisms and Clinical Implications.#343206NCBI PubMed Central
• An Intervention Study To Improve Human PapillomaVirus ( HPV) Immunization in Haitian and African American Girls#459964ClinicalTrials.gov
• Culturally Tailored HPV Psychoeducational Multimedia Intervention#865474ClinicalTrials.gov
• Partially Blind Study to Evaluate Immunogenicity & Safety of GSK Bio's HPV Vaccine 580299 in Healthy Women Aged 9-25 Yrs#852881ClinicalTrials.gov
• Long Term Immunogenicity of Quadrivalent Human Papillomavirus Vaccine (Gardasil®)in HIV-infected Adolescents and Young Adults#141075ClinicalTrials.gov
• Follow-up Study of GSK Biologicals' Human Papilloma Virus (HPV) Vaccine to Prevent Cervical Infection in Young Adults#195373ClinicalTrials.gov
• Challenges to human papillomavirus vaccination among young girls in Morocco: A national cross-sectional study.#219063NCBI PubMed Central
• The Feminization of HPV: Reversing Gender Biases in US Human Papillomavirus Vaccine Policy#384214CiNii
• Infectious Risk of Vaginal Ultrasound Examination: Evaluation and Modeling From Human Papillomavirus (HPV)#841653ClinicalTrials.gov